drugset

drugset / Trial / NCT00143117

Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

NCT00143117 ↗

Phase 2/3 Completed 460 enrolled Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

To determine whether UK-390,957 is an effective and safe treatment for premature ejaculation.

Timeline

Start: 2004-08
Primary completion: 2005-06
Completion: 2005-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	UK-390,957	Small molecule	—	—

Indications